286 related articles for article (PubMed ID: 23602652)
21. Familial pulmonary fibrosis is the strongest risk factor for idiopathic pulmonary fibrosis.
García-Sancho C; Buendía-Roldán I; Fernández-Plata MR; Navarro C; Pérez-Padilla R; Vargas MH; Loyd JE; Selman M
Respir Med; 2011 Dec; 105(12):1902-7. PubMed ID: 21917441
[TBL] [Abstract][Full Text] [Related]
22. Idiopathic pulmonary fibrosis-an epidemiological and pathological review.
Borchers AT; Chang C; Keen CL; Gershwin ME
Clin Rev Allergy Immunol; 2011 Apr; 40(2):117-34. PubMed ID: 20838937
[TBL] [Abstract][Full Text] [Related]
23. Gastroesophageal reflux therapy is associated with longer survival in patients with idiopathic pulmonary fibrosis.
Lee JS; Ryu JH; Elicker BM; Lydell CP; Jones KD; Wolters PJ; King TE; Collard HR
Am J Respir Crit Care Med; 2011 Dec; 184(12):1390-4. PubMed ID: 21700909
[TBL] [Abstract][Full Text] [Related]
24. Epithelium-dependent profibrotic milieu in the pathogenesis of idiopathic pulmonary fibrosis: current status and future directions.
Xu X; Dai H; Wang C
Clin Respir J; 2016 Mar; 10(2):133-41. PubMed ID: 25047066
[TBL] [Abstract][Full Text] [Related]
25. Osteopontin: an essential regulatory protein in idiopathic pulmonary fibrosis.
Zhu X; Ji J; Han X
J Mol Histol; 2024 Feb; 55(1):1-13. PubMed ID: 37878112
[TBL] [Abstract][Full Text] [Related]
26. Comorbidity in idiopathic pulmonary fibrosis - what can biomarkers tell us?
Alfaro TM; Robalo Cordeiro C
Ther Adv Respir Dis; 2020; 14():1753466620910092. PubMed ID: 32167024
[TBL] [Abstract][Full Text] [Related]
27. Characterizing idiopathic pulmonary fibrosis patients using US Medicare-advantage health plan claims data.
Mortimer K; Hartmann N; Chan C; Norman H; Wallace L; Enger C
BMC Pulm Med; 2019 Jan; 19(1):11. PubMed ID: 30630460
[TBL] [Abstract][Full Text] [Related]
28. Idiopathic pulmonary fibrosis: Molecular mechanisms and potential treatment approaches.
Glass DS; Grossfeld D; Renna HA; Agarwala P; Spiegler P; Kasselman LJ; Glass AD; DeLeon J; Reiss AB
Respir Investig; 2020 Sep; 58(5):320-335. PubMed ID: 32487481
[TBL] [Abstract][Full Text] [Related]
29. Screening for Helicobacter pylori in Idiopathic Pulmonary Fibrosis Lung Biopsies.
Kreuter M; Kirsten D; Bahmer T; Penzel R; Claussen M; Ehlers-Tenenbaum S; Muley T; Palmowski K; Eichinger M; Leider M; Herth FJ; Rabe KF; Bittmann I; Warth A
Respiration; 2016; 91(1):3-8. PubMed ID: 26645213
[TBL] [Abstract][Full Text] [Related]
30. Gastroesophageal Reflux Disease in Idiopathic Pulmonary Fibrosis: Uncertainties and Controversies.
Wang Z; Bonella F; Li W; Boerner EB; Guo Q; Kong X; Zhang X; Costabel U; Kreuter M
Respiration; 2018; 96(6):571-587. PubMed ID: 30308515
[TBL] [Abstract][Full Text] [Related]
31. Diagnosing complications and co-morbidities of fibrotic interstitial lung disease.
Margaritopoulos GA; Kokosi MA; Wells AU
Expert Rev Respir Med; 2019 Jul; 13(7):645-658. PubMed ID: 31215263
[No Abstract] [Full Text] [Related]
32. Smoking-related emphysema is associated with idiopathic pulmonary fibrosis and rheumatoid lung.
Antoniou KM; Walsh SL; Hansell DM; Rubens MR; Marten K; Tennant R; Hansel T; Desai SR; Siafakas NM; du Bois RM; Wells AU
Respirology; 2013 Nov; 18(8):1191-6. PubMed ID: 23819865
[TBL] [Abstract][Full Text] [Related]
33. New insights into the pathogenesis and treatment of idiopathic pulmonary fibrosis.
Ding Q; Luckhardt T; Hecker L; Zhou Y; Liu G; Antony VB; deAndrade J; Thannickal VJ
Drugs; 2011 May; 71(8):981-1001. PubMed ID: 21668038
[TBL] [Abstract][Full Text] [Related]
34. The leading role of epithelial cells in the pathogenesis of idiopathic pulmonary fibrosis.
Selman M; Pardo A
Cell Signal; 2020 Feb; 66():109482. PubMed ID: 31760172
[TBL] [Abstract][Full Text] [Related]
35. Guidelines for the diagnosis and treatment of idiopathic pulmonary fibrosis. Sociedad Española de Neumología y Cirugía Torácica (SEPAR) Research Group on Diffuse Pulmonary Diseases.
Xaubet A; Ancochea J; Bollo E; Fernández-Fabrellas E; Franquet T; Molina-Molina M; Montero MA; Serrano-Mollar A;
Arch Bronconeumol; 2013 Aug; 49(8):343-53. PubMed ID: 23742884
[TBL] [Abstract][Full Text] [Related]
36. The heterodimer S100A8/A9 is a potent therapeutic target for idiopathic pulmonary fibrosis.
Araki K; Kinoshita R; Tomonobu N; Gohara Y; Tomida S; Takahashi Y; Senoo S; Taniguchi A; Itano J; Yamamoto KI; Murata H; Suzawa K; Shien K; Yamamoto H; Okazaki M; Sugimoto S; Ichimura K; Nishibori M; Miyahara N; Toyooka S; Sakaguchi M
J Mol Med (Berl); 2021 Jan; 99(1):131-145. PubMed ID: 33169236
[TBL] [Abstract][Full Text] [Related]
37. Regeneration or Repair? The Role of Alveolar Epithelial Cells in the Pathogenesis of Idiopathic Pulmonary Fibrosis (IPF).
Confalonieri P; Volpe MC; Jacob J; Maiocchi S; Salton F; Ruaro B; Confalonieri M; Braga L
Cells; 2022 Jun; 11(13):. PubMed ID: 35805179
[TBL] [Abstract][Full Text] [Related]
38. Stem Cell and Idiopathic Pulmonary Fibrosis: Mechanisms and Treatment.
Liu M; Ren D; Wu D; Zheng J; Tu W
Curr Stem Cell Res Ther; 2015; 10(6):466-76. PubMed ID: 25986617
[TBL] [Abstract][Full Text] [Related]
39. Mesenchymal stem cells and idiopathic pulmonary fibrosis. Potential for clinical testing.
Toonkel RL; Hare JM; Matthay MA; Glassberg MK
Am J Respir Crit Care Med; 2013 Jul; 188(2):133-40. PubMed ID: 23306542
[TBL] [Abstract][Full Text] [Related]
40. Dysregulation of metabolic pathways in pulmonary fibrosis.
Rajesh R; Atallah R; Bärnthaler T
Pharmacol Ther; 2023 Jun; 246():108436. PubMed ID: 37150402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
